Skip to main content
. 2022 Oct 3;19(19):12637. doi: 10.3390/ijerph191912637

Table 3.

Retinal nerve fiber layer thickness at the peripapillary level recorded at baseline and at 3 and 12 months of follow up in patients with obstructive sleep apnea undergoing continuous positive airway pressure treatment.

Baseline 3 Months 12 Months P*
Raw
P**
Adjusted
(1) (2) (3)
RNFL_G 97.98 (±9.12) 99.51 (±9.55) 98.96 (±9.02) <0.001 <0.001
0.012
0.535
RNFL_T 72.94 (±12.67) 74.24 (±13.60) 73.69 (±12.61) 0.046 0.003
0.364
0.999
RNFL_ST 135.80 (±21.44) 136.04 (±21.83) 136.57 (±21.26) 0.581 NA
RNFL_SN 111.94 (±24.92) 114.37 (±25.12) 113.06 (±24.36) 0.014 0.004
0.170
0.215
RNFL_N 72.43 (±11.45) 74.43 (±11.63) 73.24 (±10.81) 0.001 0.001
0.392
0.137
RNFL_IN 101.94 (±20.31) 103.82 (±20.38) 103.94 (±20.25) 0.030 0.001
0.050
0.237
RNFL_IT 143.49 (±18.88) 144.82 (±20.31) 143.61 (±18.25) 0.135 NA

Data expressed as the mean (±standard deviation). P* raw: significance level obtained by repeated measures ANOVA or Friedman test (according to normality of data distribution). P** adjusted: adjusted significance level obtained through post-hoc tests for multiple comparisons: Bonferroni or Wilcoxon (according to normality of data distribution). (1) Baseline vs. 3 months. (2) Baseline vs. 12 months. (3) 3 months vs. 12 months. NA: Post-hoc test not applicable for P* greater than 0.1. Values in bold indicate p < 0.05. RNFL_G = retinal nerve fiber layer global, T = temporal, ST = superotemporal, SN = superonasal, N = nasal, IN = inferonasal, IT = inferotemporal.